Active Stock: Apple (NASDAQ AAPL) To Face Opposition Over iOS 8 Security

Apple Inc (NASDAQ AAPL) is beefing up security in its iOS 8 operating system, which may worry police officials over the difficulties this may create in enforcing the law, according to a retired police official. Raymond Foster, a retired LAPD lieutenant, told FoxNews, “It absolutely puts another hurdle in the path of law enforcement.” Apple Inc.’s new security measures for iOS 8 are not popular … Continue reading Active Stock: Apple (NASDAQ AAPL) To Face Opposition Over iOS 8 Security

Google (NASDAQ GOOG) Stock News: HTC To Work on Nexus 9 With Google

A new report indicated HTC Corp is working on the Nexus 9 tablet with Google Inc (NASDAQ GOOG). According to the Wall Street Journal, the search giant chose HTC to build the new Nexus product. In fact, HTC already met up with Google at the company’s headquarters. Google is rumored to be working on the upcoming Nexus 9 tablet with HTC with a possibility of … Continue reading Google (NASDAQ GOOG) Stock News: HTC To Work on Nexus 9 With Google

Stock in News: Facebook (NASDAQ FB) Not Charging Any Monthly Fees

In a relief, Facebook Inc (NASDAQ FB) will not charge $2.99 per month from November 1 as claimed by an article in National Report, which turns out fake. The report on the satirical website, read that the social networking site has decided to launch new monthly service plan from November 1st of this year. Facebook is not charging any monthly fee as claimed (later disclaimed) … Continue reading Stock in News: Facebook (NASDAQ FB) Not Charging Any Monthly Fees

Biotech Finance News

Biotech Stock News: Orexigen’s Obesity Drug Contrave Approved, Stock Set to Rise High

Orexigen Therapeutics, Inc. finally gained FDA approval for its weight loss drug, Contrave (NB32, naltrexone hydrochloride and bupropion hydrochloride extended-release tablets). We expect investors to react positively to the news. The FDA cleared Contrave as an adjunct to a healthy diet (low on calories) and physical activity for chronic weight management in obese (Body Mass Index, or BMI, ≥ 30) or overweight (BMI ≥ 27) … Continue reading Biotech Stock News: Orexigen’s Obesity Drug Contrave Approved, Stock Set to Rise High

A Look At Bitcoin Utilities

Though it is increasingly acknowledged by major business, investors and governments that bitcoin has the power to enable potentially world-changing financial innovations, fundamental issues are still holding back adoption. One of the most prominent, around the world, is the lack of consumer understanding of the subject. For all its development, it remains difficult to explain to the average person just how bitcoin technology can impact … Continue reading A Look At Bitcoin Utilities

Stock News: With Windows 9, Microsoft (NASDAQ MSFT) Stock Set For a Sharp Rise

Microsoft Corporation (NASDAQ MSFT) has sent out invites for its September 30 media event. The company will take the wraps off its next-gen Windows 9 Enterprise Technical Preview. The invitation itself has the theme “What’s next for Windows?” Veteran Windows watcher Paul Thurrott said that Windows 8 was even bigger disaster than Windows Vista. Windows 9 is getting some useful Windows Phone features such as … Continue reading Stock News: With Windows 9, Microsoft (NASDAQ MSFT) Stock Set For a Sharp Rise